Aldosterone receptor antagonists (MRAs) for HF

0.0(0)
studied byStudied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/5

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 6:38 PM on 10/10/25
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

6 Terms

1
New cards

What is the basic MOA of MRAs?

blockade of aldosterone receptors

2
New cards

What are the 4 mechanisms of cardiac death?

  • coronary endothelial dysfunction

  • LV abnormalities

  • extrinsic arrhythmogenic influences

  • autonomic dysfunction

3
New cards

What is the effect of aldosterone receptor antagonists and how do they happen?

  • increased sodium and water retention leads to congestive symptoms and cardiac remodelling so blocking these receptors has the opposite effect

  • increased proliferative effects lead to hypertrophy, apoptosis and fibrosis lead to cardiac remodelling, so MRAs block that

4
New cards

What is the clinical use of MRAs for?

All patients with heart failure with reduced ejection fraction.

5
New cards

Which MRAs are licensed for use in HF in the UK?

spironolactone and eplerenone

6
New cards

What are the possible adverse effects of MRAs?

  • impotence and gynaecomastia

  • menstrual disorders and hirsutism

  • hyperkalaemia